MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia

被引:305
作者
Chen, Chong [1 ]
Liu, Yu [1 ]
Rappaport, Amy R. [2 ]
Kitzing, Thomas [1 ]
Schultz, Nikolaus [3 ]
Zhao, Zhen [1 ]
Shroff, Aditya S. [1 ]
Dickins, Ross A. [4 ]
Vakoc, Christopher R. [2 ]
Bradner, James E. [5 ]
Stock, Wendy [6 ]
LeBeau, Michelle M. [6 ]
Shannon, Kevin M. [7 ]
Kogan, Scott [8 ,9 ]
Zuber, Johannes [2 ,10 ]
Lowe, Scott W. [1 ,11 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA
[2] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[3] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA
[4] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia
[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[6] Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA
[7] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA
[8] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94158 USA
[9] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA
[10] Res Inst Mol Pathol, A-1030 Vienna, Austria
[11] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA
关键词
HEMATOPOIETIC-CELLS; GENOME; GENE; CHROMATIN; INACTIVATION; MUTATIONS; PATHWAYS; MOUSE; P53; RECRUITMENT;
D O I
10.1016/j.ccr.2014.03.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Recurring deletions of chromosome 7 and 7q [-7/del(7q)] occur in myelodysplastic syndromes and acute myeloid leukemia (AML) and are associated with poor prognosis. However, the identity of functionally relevant tumor suppressors on 7q remains unclear. Using RNAi and CRISPR/Cas9 approaches, we show that an -50% reduction in gene dosage of the mixed lineage leukemia 3 (MLL3) gene, located on 7q36.1, cooperates with other events occurring in -7/del(7q) AMLs to promote leukemogenesis. Mll3 suppression impairs the differentiation of HSPC. Interestingly, Mll3-suppressed leukemias, like human -7/del(7q) AMLs, are refractory to conventional chemotherapy but sensitive to the BET inhibitor JQ1. Thus, our mouse model functionally validates MLL3 as a haploinsufficient 7q tumor suppressor and suggests a therapeutic option for this aggressive disease.
引用
收藏
页码:652 / 665
页数:14
相关论文
共 61 条
[1]
Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome [J].
Asou, Hiroya ;
Matsui, Hirotaka ;
Ozaki, Yuko ;
Nagamachi, Akiko ;
Nakamura, Megumi ;
Aki, Daisuke ;
Inaba, Toshiya .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 383 (02) :245-251
[2]
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis [J].
Balgobind, Brian V. ;
Van Vlierberghe, Pieter ;
van den Ouweland, Ans M. W. ;
Beverloo, H. Berna ;
Terlouw-Kromosoeto, Joan N. R. ;
van Wering, Elisabeth R. ;
Reinhardt, Dirk ;
Horstmann, Martin ;
Kaspers, Gertjan J. L. ;
Pieters, Rob ;
Zwaan, C. Michel ;
Van den Heuvel-Eibrink, Marry M. ;
Meijerink, Jules P. P. .
BLOOD, 2008, 111 (08) :4322-4328
[3]
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J].
Bollag, G ;
Clapp, DW ;
Shih, S ;
Adler, F ;
Zhang, YY ;
Thompson, P ;
Lange, BJ ;
Freedman, MH ;
McCormick, F ;
Jacks, T ;
Shannon, K .
NATURE GENETICS, 1996, 12 (02) :144-148
[4]
Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[5]
Myelodysplastic syndromes: the complexity of stem-cell diseases [J].
Corey, Seth J. ;
Minden, Mark D. ;
Barber, Dwayne L. ;
Kantarjian, Hagop ;
Wang, Jean C. Y. ;
Schimmer, Aaron D. .
NATURE REVIEWS CANCER, 2007, 7 (02) :118-129
[6]
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia [J].
Dawson, Mark A. ;
Prinjha, Rab K. ;
Dittmann, Antje ;
Giotopoulos, George ;
Bantscheff, Marcus ;
Chan, Wai-In ;
Robson, Samuel C. ;
Chung, Chun-wa ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Huthmacher, Carola ;
Gudgin, Emma ;
Lugo, Dave ;
Beinke, Soren ;
Chapman, Trevor D. ;
Roberts, Emma J. ;
Soden, Peter E. ;
Auger, Kurt R. ;
Mirguet, Olivier ;
Doehner, Konstanze ;
Delwel, Ruud ;
Burnett, Alan K. ;
Jeffrey, Phillip ;
Drewes, Gerard ;
Lee, Kevin ;
Huntly, Brian J. P. ;
Kouzarides, Tony .
NATURE, 2011, 478 (7370) :529-533
[7]
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors [J].
Dickins, RA ;
Hemann, MT ;
Zilfou, JT ;
Simpson, DR ;
Ibarra, I ;
Hannon, GJ ;
Lowe, SW .
NATURE GENETICS, 2005, 37 (11) :1289-1295
[8]
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].
Doehner, Hartmut ;
Estey, Elihu H. ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Burnett, Alan K. ;
Dombret, Herve ;
Fenaux, Pierre ;
Grimwade, David ;
Larson, Richard A. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel A. ;
Sierra, Jorge ;
Tallman, Martin S. ;
Loewenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2010, 115 (03) :453-474
[9]
MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[10]
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials [J].
Grimwade, David ;
Hills, Robert K. ;
Moorman, Anthony V. ;
Walker, Helen ;
Chatters, Stephen ;
Goldstone, Anthony H. ;
Wheatley, Keith ;
Harrison, Christine J. ;
Burnett, Alan K. .
BLOOD, 2010, 116 (03) :354-365